Labetuzumab govitecan | MedChemExpress (MCE)
Labetuzumab govitecan (IMMU 130) is an Anti-CEACAM5/SN-38 antibody-drug conjugate (ADC). Labetuzumab govitecan consists of the antibody Labetuzumab, SN-38, and a pH-sensitive Linker. Labetuzumab govitecan can be used for research of cancers, such as colorectal cancer[1][2][3].
| Trivial name | Labetuzumab govitecan |
| Catalog Number | HY-P99681 |
| Alternative Name(s) | IMMU 130; hMN-14-SN-38 |
| Research Area | Cancer |
| CAS# | 1469876-18-3 |
| Purity | 98.33% |
| SMILES | [Labetuzumab govitecan] |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/labetuzumab-govitecan.html |